Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,893-5,904 of 10,592
Behavioral study icon
CompletedNCT00751946

Girls In Recovery From Life Stress (GIRLS) Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralFrom 13 Years to 17 Years
Countries
United States
Sponsor
UConn Health
Condition
PTSD
Drug study icon
CompletedNCT05446857

Glecaprevir/Pibrentasvir for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugA study involving a medication or substance.From 19 Years to 70 Years
Countries
United States
Sponsor
White River Junction Veterans Affairs Medical Center
Condition
PTSD
Drug study icon
CompletedNCT07368855

GLP-1 Medicines and Mental Health Changes

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve sleep, daily rhythms, and longer-term stability.

In United States
DepressionDrug
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Drug study icon
TerminatedNCT03248713

Glucocorticoid Antagonist Treatment for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Drug study icon
CompletedNCT00515723

Glucose and Lipid Metabolism on Antipsychotic Medication

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Schizophrenia
Drug study icon
CompletedNCT03321617

Glutamate Reducing Interventions in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 30 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT04589208

Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

Remote / online
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Other study type icon
CompletedNCT01558557

Gluten Free Diet in People With Schizophrenia: A Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
WithdrawnNCT00000372

Glycine and D-Cycloserine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00291226

Glycine vs Placebo for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 13 Years to 35 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.